Advertisement

Topics

APC, Glenmark sign deal for cell-based anticancer drug

10:56 EDT 22 Jun 2017 | SmartBrief

Glenmark Pharmaceuticals gained an exclusive license to APC Therapeutics' antigen-presenting, cell technology-based anticance -More

Original Article: APC, Glenmark sign deal for cell-based anticancer drug

NEXT ARTICLE

More From BioPortfolio on "APC, Glenmark sign deal for cell-based anticancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...